PMID: 18717433Aug 23, 2008Paper

Macular holes associated with diabetic tractional retinal detachments

Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye
John O MasonRachel S Vail

Abstract

Evaluation of surgical treatment of full-thickness macular holes secondary to diabetic tractional retinal detachments was conducted. A retrospective review of medical records, fluorescein angiograms, fundus photographs, optical coherence tomography images, and operative findings of six consecutive patients with full-thickness macular holes and diabetic tractional retinal detachments was completed. Each eye was treated with pars plana vitrectomy, tractional retinal detachment repair, membranectomy, indocyanine green-assisted internal limiting membrane peeling, and intraocular gas tamponade. Surgical intervention resulted in the closure of all full-thickness macular holes. Mean best-corrected visual acuity was 20/250 preoperatively and 20/100 postoperatively, with all patients having improvement after a mean follow-up of 10 months. Closure of tractional retinal detachments related to full-thickness macular holes can be achieved via pars plana vitrectomy, complete membranectomy, and intraocular gas. Vitrectomy with dissection of proliferative membranes helps to relieve the tractional forces responsible for full-thickness macular hole formation, enabling successful closure of the diabetic full-thickness macular holes and resulting ...Continue Reading

References

Jul 1, 1994·Archives of Ophthalmology·H W Flynn
Apr 21, 1998·Survey of Ophthalmology·A C HoS L Fine
Jul 15, 2000·Documenta Ophthalmologica. Advances in Ophthalmology·P D Brazitikos, N T Stangos

❮ Previous
Next ❯

Citations

Jul 16, 2011·Expert Review of Ophthalmology·Kathryn SkarbezSteven B Koevary
Apr 1, 2020·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Divya JagadeeshPadmaja Sankaridurg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.